It’s hard to believe, but over the past year, the pharmaceutical industry has fared worse in the stock market than the energy sector. Some sword-rattling from political candidates sent the SPDR S&P Pharmaceutical ETF (NYSEMKT: XPH) crashing to a level it hasn’t seen since late 2013.